Possible role of neuromelanin in the pathogenesis of Parkinson's disease

https://doi.org/10.1016/0047-6374(83)90074-XGet rights and content

Abstract

The numbers of nerve cells in the substantia nigra and locus caeruleus were counted, and the volume of their nucleolus and the amount of neuromelanin pigment they contain measured, in patients with Parkinson's disease and in age-matched and elderly individuals free from neurological illness.

The number of pigmented nerve cells of both types is reduced by about 20% in the elderly when compared with age-matched controls. The melanin content of the remaining cells in the elderly is lessened (by 11% in substantia nigra and 21% in locus caeruleus) in such a way as to indicate that this age depletion in cell number results from a preferential loss of those nerve cells which contain the greatest amounts of melanin pigment. In Parkinson's disease there is a greater overall reduction in the amount of melanin within remaining cells (15% in substantia nigra, 25% in locus caeruleus) because of a more severe (80%) loss of the heavier pigmented cells. The basis for Parkinson's disease may therefore lie with an aggravation, possibly by secondary factors, of changes that occur within neurones of substantia nigra and locus caeruleus as part of their “normal” process of ageing.

References (28)

  • J.G. Greenfield et al.

    The brain stem lesions in Parkisonism

    J. Neurol. Neurosurg. Psychiatr.

    (1953)
  • P. Riederer et al.

    Time course of nigrostriatal degeneration in Parkison's disease

    J. Neural Transm.

    (1976)
  • P. Riederer et al.

    Brain noradrenaline and 3-methoxy-4-hydroxy phenylglycol in Parkinson's syndrome

    J. Neural Transm.

    (1977)
  • D.M.A. Mann et al.

    Lipoprotein pigments — their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells

    Brain

    (1974)
  • H.J. Scherer

    Melanin pigmentation of the substantia nigra in primates

    J. Comp. Neurol.

    (1939)
  • A. Adler

    Melanin pigment in the brain of a gorilla

    J. Comp. Neurol.

    (1942)
  • C.D. Marsden

    Pigmentation in the nucleus substantine nigrae of mammals

    J. Anat.

    (1961)
  • D.M.A. Mann et al.

    Melanin and RNA in cells of the human substantia nigra

    J. Neuropathol. Exp. Neurol.

    (1977)
  • D.M.A. Mann et al.

    The effects of ageing on the pigmented nerve cells of the human locus caeruleus and substantia nigra

    Acta Neuropathol.

    (1979)
  • P.L. McGeer et al.

    Ageing and extrapyramidal function

    Arch. Neurol.

    (1977)
  • N. Vijayashankar et al.

    A quantitative study of the pigmented neurones in the nuclei of locus caeruleus and sub-caeruleus in man, as related to ageing

    J. Neuropathol. Exp. Neurol.

    (1979)
  • D.M.A. Mann, P.O. Yates and J. Hawkes, The pathology of the human locus caeruleus. Clin. Neuropathol., in...
  • D.M.A. Mann

    Nerve cell protein metabolism and degenerative disease

    Neuropathol. Appl. Neurobiol.

    (1982)
  • D.M.A. Mann et al.

    Lipoprotein pigments — their relationship to ageing in the human nervous system. I. The lipofuscin content of nerve cells

    Brain

    (1974)
  • Cited by (187)

    • Neuropeptide-S prevents 6-OHDA-induced gastric dysmotility in rats

      2021, Brain Research
      Citation Excerpt :

      Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by degeneration of dopamine-synthesizing neurons in substantia nigra pars compacta (SNpc) (Mann and Yates, 1983).

    • Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells

      2019, European Journal of Medicinal Chemistry
      Citation Excerpt :

      In addition to melanin biosynthesis, tyrosinase is also involved in the defensive and developmental functions of the pests [20,21]. Excessive dopaquinone produced by the catalysis of tyrosinase has been reported to cause the neurodegeneration associated with Parkinson's disease in the brain [22–26]. Therefore, suitable new tyrosinase inhibitors might be applied to pesticides with a novel mode of action and medications associated with neuronal damages.

    View all citing articles on Scopus
    View full text